Stuelpnagel John R 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/12/3 申報
- 申報編號
- 0001567619-21-021614
- 申報時間
- 2021/12/3
- 交易日
- 2021/12/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $75.6 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Stuelpnagel John RCIK 0001189140 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/1 | Class A Common Stock | S賣出處分 | −2,000 | $150.51F2 | −$301,020 | 349,616 | 直接 | |
| 2021/12/1 | Class A Common Stock | S賣出處分 | −1,700 | $151.10F3 | −$256,870 | 347,916 | 直接 | |
| 2021/12/1 | Class A Common Stock | S賣出處分 | −1,100 | $151.79F4 | −$166,969 | 346,816 | 直接 | |
| 2021/12/1 | Class A Common Stock | S賣出處分 | −100 | $154.02 | −$15,402 | 346,716 | 直接 | |
| 2021/12/1 | Class A Common Stock | S賣出處分 | −100 | $155.55 | −$15,555 | 346,616 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $150.00 to $150.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $151.00 to $151.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $151.53 to $152.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。